# EDGAR Filing Document

**Accession Number:** 0001341439
**File Stem:** 0001193125-25-291441
**Filing Date:** 2025-11
**Character Count:** 11599
**Document Hash:** bfffe520a0d7576a08b0800646e95d3a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-291441.hdr.sgml**: 20251121

**ACCESSION NUMBER**: 0001193125-25-291441

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20251118

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20251121

**DATE AS OF CHANGE**: 20251121

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ORACLE CORP
- **CENTRAL INDEX KEY:** 0001341439
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-PREPACKAGED SOFTWARE [7372]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 542185193
- **FISCAL YEAR END:** 0531

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-35992
- **FILM NUMBER:** 251508356

**BUSINESS ADDRESS:**
- **STREET 1:** 2300 ORACLE WAY
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78741
- **BUSINESS PHONE:** (737) 867-1000

**MAIL ADDRESS:**
- **STREET 1:** 2300 ORACLE WAY
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78741

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Ozark Holding Inc.
- **DATE OF NAME CHANGE:** 20051013

?xml version='1.0' encoding='ASCII'? 8-K

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

#### Washington, D.C. 20549

### FORM 8-K

#### CURRENT REPORT

#### Pursuant to Section 13 OR 15(d)

#### of the Securities Exchange Act of 1934

#### Date of Report (Date of earliest event reported): November 18, 2025

## Oracle Corporation

#### (Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| Delaware | 001-35992 | 54-2185193 |
|  **(State or other jurisdiction of**<br> **incorporation)** | **(Commission**<br> **File Number)** | **(IRS Employer**<br> **Identification No.)** |

---

#### 2300 Oracle Way, Austin, Texas 78741

#### (Address of principal executive offices) (Zip Code)
(737) 867-1000

#### (Registrant's telephone number, including area code)

#### N/A

#### (Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
|  **Title of each class** | Trading Symbol(s) | Name of each exchange on which registered |
|  Common Stock, par value $0.01 per share | ORCL | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

#### Section 5—Corporate Governance and Management

#### Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On November 18, 2025, the Board of Directors of Oracle Corporation ("Oracle") unanimously elected Stephen Rusckowski to serve as a director, effective immediately.

Mr. Rusckowski will be granted restricted stock units for shares of Oracle common stock (the "RSUs") in accordance with Oracle's Amended and Restated 1993 Directors' Stock Plan. The RSUs will represent a pro rata amount of the annual equity award granted to non-employee directors based on the number of complete calendar months remaining in Oracle's current fiscal year. The RSUs will fully vest on the first anniversary of the date of grant provided Mr. Rusckowski continues to serve as a director on the vest date. Mr. Rusckowski will also receive the standard cash compensation for Oracle's non-employee directors.

Mr. Rusckowski entered into Oracle's standard form of indemnification agreement pursuant to which Oracle will indemnify him for certain actions taken in his capacity as a director.

#### Item 5.07 Submission of Matters to a Vote of Security Holders
On November 18, 2025, Oracle held its 2025 Annual Meeting of Stockholders (the "Annual Meeting"). Below is a brief description of each matter submitted to a vote at the Annual Meeting, as well as the final voting results with respect to each matter. For more information about these proposals, please refer to Oracle's definitive proxy statement filed with the U.S. Securities and Exchange Commission on September 26, 2025.

#### Proposal No. 1: Election of Directors
The stockholders elected each of the following persons as a director to hold office until the 2026 Annual Meeting of Stockholders and until his or her successor is elected and qualified, or until his or her earlier resignation or removal.

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; **Director Nominee** | Votes For | Votes Withheld | Broker Non-Votes |
| &nbsp;&nbsp;&nbsp; Awo Ablo | 1970921678 | 379377888 | 265704606 |
| &nbsp;&nbsp;&nbsp; Jeffrey S. Berg | 2167434409 | 182865157 | 265704606 |
| &nbsp;&nbsp;&nbsp; Michael J. Boskin | 2144795282 | 205504284 | 265704606 |
| &nbsp;&nbsp;&nbsp; Safra A. Catz | 2287398391 | 62901175 | 265704606 |
| &nbsp;&nbsp;&nbsp; Bruce R. Chizen | 1789428191 | 560871375 | 265704606 |
| &nbsp;&nbsp;&nbsp; George H. Conrades | 2168501144 | 181798422 | 265704606 |
| &nbsp;&nbsp;&nbsp; Lawrence J. Ellison | 2271537382 | 78762184 | 265704606 |
| &nbsp;&nbsp;&nbsp; Rona A. Fairhead | 2311910112 | 38389454 | 265704606 |
| &nbsp;&nbsp;&nbsp; Jeffrey O. Henley | 2161523700 | 188775866 | 265704606 |
| &nbsp;&nbsp;&nbsp; Clayton M. Magouyrk | 2309110378 | 41189188 | 265704606 |
| &nbsp;&nbsp;&nbsp; Charles W. Moorman | 2297980595 | 52318971 | 265704606 |
| &nbsp;&nbsp;&nbsp; Naomi O. Seligman | 2175743875 | 174555691 | 265704606 |
| &nbsp;&nbsp;&nbsp; Michael D. Sicilia | 2309260122 | 41039444 | 265704606 |

---

#### Proposal No. 2: Advisory Vote to Approve the Compensation of Oracle's Named Executive Officers
The stockholders cast an advisory vote approving the compensation of Oracle's named executive officers as follows: 1,922,942,188 shares in favor, 423,773,929 shares against, 3,583,449 shares abstaining and 265,704,606 broker non-votes.

#### Proposal No. 3: Ratification of Selection of Independent Registered Public Accounting Firm
The stockholders ratified the appointment of Ernst & Young LLP as Oracle's independent registered public accounting firm for the fiscal year ending May 31, 2026, with 2,549,762,065 shares in favor, 63,419,255 shares against and 2,822,852 shares abstaining.

------

#### Section 9—Financial Statements and Exhibits

#### Item 9.01 Financial Statements and Exhibits
(d) Exhibits

---

| | |
|:---|:---|
| Exhibit<br>No. | Description |
| 99.1 | [Press Release – Oracle Names Stephen Rusckowski to the Board of Directors, dated November 20, 2025](d43173dex991.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

------

#### SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | ORACLE CORPORATION | ORACLE CORPORATION |
|  Dated: November 21, 2025 | By: | /s/ Kimberly Woolley |
|  |  | Name: Kimberly Woolley |
|  |  | Title: Vice President, Assistant General Counsel and<br>Assistant Secretary |

---

## Exhibit 99.1

**Exhibit 99.1**![LOGO](g43173g1121070934115.jpg)

---

| | | |
|:---|:---|:---|
| Contact: | Ken Bond | Deborah Hellinger |
|  | Oracle Investor Relations | Oracle Corporate Communications |
|  | 1.650.607.0349 | 1.212.508.7935 |
|  | ken.bond@oracle.com | deborah.hellinger@oracle.com |

---

**Oracle Names Stephen Rusckowski to the Board of Directors** 

AUSTIN, Texas, November 20, 2025 — Oracle Corporation (NYSE: ORCL) today announced that it unanimously elected Stephen Rusckowski to Oracle's Board of Directors and increased the size of the Board to 14. The election is effective as of November 18, 2025.

Mr. Rusckowski is the former Chief Executive Officer and President of Quest Diagnostics, Inc. (Quest), a leading provider of diagnostic information, a position he held from 2012 until 2022. He also served as Chair of the Board of Quest from January 2017 through March 2023. Prior to joining Quest, he served as the Chief Executive Officer of Philips Healthcare, and a member of the Board of Management of Royal Philips Electronics. Mr. Rusckowski currently serves on the supervisory board of Qiagen N.V. and as a director of Baxter International Inc. Mr. Rusckowski earned a Bachelor of Science degree in Mechanical Engineering from Worcester Polytechnic Institute and a Master of Science degree in Management from the Massachusetts Institute of Technology's Sloan School of Management.

"Steve's years of experience in healthcare and technology will enable him to provide the Oracle Board with a unique perspective as to how Oracle Health can better serve patients and healthcare providers around the world," said Larry Ellison, Oracle's Board Chairman and Chief Technology Officer.

Bruce Chizen, Chair of the Nomination and Governance Committee, added, "I am pleased to welcome Steve to the Board. We believe that Oracle, along with its customers and shareholders, will benefit from his extensive experience in leading and advising global healthcare organizations."

Members of Oracle's Board of Directors serve one-year terms and will next stand for election at the company's annual meeting of stockholders in November 2026.

**About Oracle** 

Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at <u>www.oracle.com</u>.

**Trademarks** 

Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.

------

**"Safe Harbor" Statement:** Statements in this press release relating to Oracle's future plans, expectations, beliefs, intentions, and prospects are "forward-looking statements" and are subject to material risks and uncertainties. A detailed discussion of these factors and other risks that affect our business is contained in Oracle's Securities and Exchange Commission (SEC) filings, including our most recent reports on Form 10-K and Form 10-Q under the heading "Risk Factors." These filings are available on the SEC's website or on Oracle's website at http://www.oracle.com/investor. All information in this press release is current as of November 20, 2025, and Oracle undertakes no duty to update any statement in light of new information or future events.